Raziel Therapeutics
PrivateLast Round
Strategic
Jun 28, 2026
Total Funding Raised
$27.1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Raziel Therapeutics is a clinical-stage pharmaceutical company developing a proprietary injectable compound for non-surgical, targeted fat reduction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Raziel Therapeutics Comparables
Compare Raziel Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Caliway Biopharmaceuticals | 87% | |
| AMI Pharm Co., Ltd. | 83% | |
| Marllor Biomedical | 81% | |
Raziel Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 28, 2026 | ||||
| Strategic | Oct 30, 2025 | ||||
| Series C | Dec 18, 2019 | ||||
| Series A | Feb 1, 2016 | ||||
| Seed | Dec 1, 2014 |
Raziel Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Seed |
| Pontifax Venture Capital | Series A, Series C |
| Docor International Management | Series A, Series C |
| Catalyst Investments Group | Series C |
| Wille Finance AG | Series C |
| Peregrine Ventures | Strategic, Series C |
| VLX Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 28, 2026
Raised a strategic round with GC Wellbeing as an investor.
- Oct 30, 2025
Raised capital from Peregrine Ventures and 365mc.
Raziel Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Raziel Therapeutics's valuation, stock price, and market status.